Goldman Sachs Group Inc. Reduces Stake in HCA Healthcare, Inc. $HCA

Goldman Sachs Group Inc. lowered its position in HCA Healthcare, Inc. (NYSE:HCA) by 2.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,771,281 shares of the company’s stock after selling 40,931 shares during the period. Goldman Sachs Group Inc.’s holdings in HCA Healthcare were worth $826,941,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also bought and sold shares of the stock. MJP Associates Inc. ADV boosted its position in HCA Healthcare by 2.9% in the 4th quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock worth $350,000 after purchasing an additional 21 shares in the last quarter. Cary Street Partners Investment Advisory LLC boosted its position in HCA Healthcare by 7.5% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock worth $140,000 after purchasing an additional 21 shares in the last quarter. Centerpoint Advisors LLC boosted its position in HCA Healthcare by 11.0% in the 3rd quarter. Centerpoint Advisors LLC now owns 222 shares of the company’s stock worth $95,000 after purchasing an additional 22 shares in the last quarter. Cary Street Partners Financial LLC boosted its position in HCA Healthcare by 3.9% in the 3rd quarter. Cary Street Partners Financial LLC now owns 590 shares of the company’s stock worth $251,000 after purchasing an additional 22 shares in the last quarter. Finally, Plato Investment Management Ltd boosted its position in HCA Healthcare by 0.6% in the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock worth $1,833,000 after purchasing an additional 22 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

HCA has been the subject of several research analyst reports. Jefferies Financial Group reaffirmed a “buy” rating and set a $525.00 target price on shares of HCA Healthcare in a research note on Friday, April 24th. Barclays reduced their target price on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Mizuho upped their target price on HCA Healthcare from $540.00 to $585.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 25th. KeyCorp reduced their target price on HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Finally, Wells Fargo & Company reduced their target price on HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating for the company in a research note on Monday, April 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $515.77.

HCA Healthcare Stock Performance

NYSE HCA opened at $364.00 on Thursday. The business has a fifty day moving average price of $444.21 and a 200 day moving average price of $478.72. HCA Healthcare, Inc. has a one year low of $330.00 and a one year high of $556.52. The company has a market cap of $80.75 billion, a P/E ratio of 12.52, a P/E/G ratio of 1.16 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. During the same period in the prior year, the company posted $6.45 earnings per share. The firm’s revenue for the quarter was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts predict that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.9%. HCA Healthcare’s payout ratio is presently 10.73%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.